Prosecution Insights
Prosecution Insights
11 pending office actions • 2 clients • 8 examiners • 4 art units • 0 of 11 (0%) have an AI response strategy ready • 15 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (9%) |
| §101 + other | 1 (9%) |
| §103 only | 4 (36%) |
| Double-patenting + other | 1 (9%) |
| Multi-statute (no §101) | 4 (36%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DINH, ANH-KHOA N | 3 | 87.0% | +15.3% |
| KAHELIN, MICHAEL WILLIAM | 2 | 77.8% | +23.9% |
| HULBERT, AMANDA K | 1 | 84.5% | +4.0% |
| SOLOMON, JOSHUA BRENDON | 1 | 82.6% | +20.8% |
| BEHARRY, ZANNA MARIA | 1 | 23.2% | +52.7% |
| BRETZ, COREY LANE | 1 | 0.0% | +0.0% |
| MARLEN, TAMMIE K | 1 | 75.1% | +21.2% |
| SAHAND, SANA | 1 | 63.4% | +24.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18337747 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND VEGF INHIBITORS | DINH, ANH-KHOA N | 22d |
| 18398714 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND ANTI-VEGFR-2 ANTIBODIES | DINH, ANH-KHOA N | 34d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18475497 | INGESTIBLE IMPLANTABLE DEVICE TO MEASURE INTERNAL TTFIELD INTENSITY | DINH, ANH-KHOA N | 9d overdue |
| 18476573 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING ALTERNATING ELECTRIC FIELDS AND APOPTOTIC CANCER CELL VACCINATION | BEHARRY, ZANNA MARIA | 22d |
| 18511374 | CONDUCTIVE GEL COMPOSITIONS COMPRISING BULK ELECTRON TRANSPORT AGENTS AND METHODS OF PRODUCTION AND USE THEREOF | KAHELIN, MICHAEL WILLIAM | 75d |
| 18622108 | MICRONEEDLES TO OVERCOME CONTACT RESISTANCE | HULBERT, AMANDA K | — |
| 18619957 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND KILLER CELLS | SOLOMON, JOSHUA BRENDON | — |
| 18336493 | SYSTEMS AND METHODS FOR TREATING CONDITIONS AND DISEASES USING ALTERNATING ELECTRIC FIELDS AND CRISPR-CAS SYSTEM | BRETZ, COREY LANE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18475497 | INGESTIBLE IMPLANTABLE DEVICE TO MEASURE INTERNAL TTFIELD INTENSITY | DINH, ANH-KHOA N | 9d overdue |
| 18062372 | GARMENT PROVIDING A BIASING FORCE ON A TRANSDUCER ARRAY | SAHAND, SANA | 8d overdue |
| 18476573 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING ALTERNATING ELECTRIC FIELDS AND APOPTOTIC CANCER CELL VACCINATION | BEHARRY, ZANNA MARIA | 22d |
| 18337747 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND VEGF INHIBITORS | DINH, ANH-KHOA N | 22d |
| 18398714 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND ANTI-VEGFR-2 ANTIBODIES | DINH, ANH-KHOA N | 34d |
| 18511374 | CONDUCTIVE GEL COMPOSITIONS COMPRISING BULK ELECTRON TRANSPORT AGENTS AND METHODS OF PRODUCTION AND USE THEREOF | KAHELIN, MICHAEL WILLIAM | 75d |
| 18806445 | CONNECTOR FOR DETACHABLE ARRAY | KAHELIN, MICHAEL WILLIAM | — |
| 18619957 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND KILLER CELLS | SOLOMON, JOSHUA BRENDON | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Novocure | 10 |
| Novocure GmbH | 1 |
| Art Unit | Apps |
|---|---|
| 3796 | 5 |
| 3792 | 3 |
| 1632 | 1 |
| 1635 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18806445 | CONNECTOR FOR DETACHABLE ARRAY | Novocure GmbH | KAHELIN, MICHAEL WILLIAM | 3792 | §102§103DP | Non-Final OA | — | Pending | Aug 15, 2024 |
| 18622108 | MICRONEEDLES TO OVERCOME CONTACT RESISTANCE | Novocure GmbH | HULBERT, AMANDA K | 3792 | §101§102§103§112 | Non-Final OA | — | Pending | Mar 29, 2024 |
| 18619957 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND KILLER CELLS | Novocure GmbH | SOLOMON, JOSHUA BRENDON | §102§103 | Non-Final OA | — | Pending | Mar 28, 2024 | |
| 18398714 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND ANTI-VEGFR-2 ANTIBODIES | Novocure GmbH | DINH, ANH-KHOA N | 3796 | §103 | Final Rejection | 34d | Pending | Dec 28, 2023 |
| 18511374 | CONDUCTIVE GEL COMPOSITIONS COMPRISING BULK ELECTRON TRANSPORT AGENTS AND METHODS OF PRODUCTION AND USE THEREOF | Novocure GmbH | KAHELIN, MICHAEL WILLIAM | 3792 | §102§103 | Non-Final OA | 75d | Pending | Nov 16, 2023 |
| 18476573 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING ALTERNATING ELECTRIC FIELDS AND APOPTOTIC CANCER CELL VACCINATION | Novocure GmbH | BEHARRY, ZANNA MARIA | 1632 | §103§112 | Non-Final OA | 22d | Pending | Sep 28, 2023 |
| 18475497 | INGESTIBLE IMPLANTABLE DEVICE TO MEASURE INTERNAL TTFIELD INTENSITY | Novocure GmbH | DINH, ANH-KHOA N | 3796 | §101 | Non-Final OA | 9d overdue | Pending | Sep 27, 2023 |
| 18337747 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND VEGF INHIBITORS | Novocure GmbH | DINH, ANH-KHOA N | 3796 | §103 | Final Rejection | 22d | Pending | Jun 20, 2023 |
| 18336493 | SYSTEMS AND METHODS FOR TREATING CONDITIONS AND DISEASES USING ALTERNATING ELECTRIC FIELDS AND CRISPR-CAS SYSTEM | Novocure GmbH | BRETZ, COREY LANE | 1635 | §102§103Other | Non-Final OA | — | Pending | Jun 16, 2023 |
| 18063464 | COMPRESSION GARMENT ASSEMBLY FOR APPLYING TTFIELDS AND METHODS OF PRODUCTION AND USE THEREOF | Novocure GmbH | MARLEN, TAMMIE K | 3796 | §103 | Non-Final OA | — | Pending | Dec 08, 2022 |
| 18062372 | GARMENT PROVIDING A BIASING FORCE ON A TRANSDUCER ARRAY | Novocure GmbH | SAHAND, SANA | 3796 | §103 | Non-Final OA | 8d overdue | Pending | Dec 06, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial